Moulignier, Antoine http://orcid.org/0000-0001-7566-0175
,
Viret-Vilayphon, Anne-Claire
Lescure, François-Xavier
Plaisier, Emmanuelle
Salomon, Laurence
Lamirel, Cédric
Pialoux, Gilles
Article History
Received: 19 August 2019
Revised: 5 November 2019
Accepted: 11 December 2019
First Online: 24 January 2020
Compliance with ethical standards
:
: A. Moulignier: no disclosures. A.-C. Viret-Vilayphon: no disclosures. F.-X. Lescure: no disclosures. E. Plaisier: no disclosures. L. Salomon: no disclosures. C. Lamirel: honoraria from Novartis and Allergan for lectures; from Horus Pharma for consulting or an advisory role; from Allergan for travel, accommodations, and expenses. G. Pialoux: honoraria from Bristol-Myers Squibb, Viiv Healthcare, Gilead Sciences for lectures for consulting or an advisory role.
: The ALCOVE study was approved by the CPP Île-de-France VI, Groupe Hospitalier Pitié–Salpêtrière Ethics Committee, and adhered to the tenets of the Declaration of Helsinki.
: Written informed consent was obtained from all participants.